1.
F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients
by Giesel, Frederik L
European journal of nuclear medicine and molecular imaging, 2016-11-26, Vol.44 (4), p.678-688
2.
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals
by Elsinga, Philip
European journal of nuclear medicine and molecular imaging, 2010-05, Vol.37 (5), p.1049-1062
3.
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors
by Bodei, L
European journal of nuclear medicine and molecular imaging, 2015, Vol.42 (1), p.5-19
4.
European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma...
by Taieb, D
European journal of nuclear medicine and molecular imaging, 2019, Vol.46 (10), p.2112-2137
5.
Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study
by Bodei, Lisa
European journal of nuclear medicine and molecular imaging, 2011-09-03, Vol.38 (12), p.2125-2135
6.
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds
by Giammarile, F
European journal of nuclear medicine and molecular imaging, 2011, Vol.38 (7), p.1393-1406
7.
Phase I pharmacokinetic and biodistribution study with escalating doses of 223Ra-dichloride in men with castration-resistant metastatic prostate cancer
by Carrasquillo, Jorge A
European journal of nuclear medicine and molecular imaging, 2013-05-08, Vol.40 (9), p.1384-1393
8.
Consequences of radiopharmaceutical extravasation and therapeutic interventions: a systematic review
by van der Pol, Jochem
European journal of nuclear medicine and molecular imaging, 2017-07, Vol.44 (7), p.1234-1243
9.
Current use and future potential of organometallic radiopharmaceuticals
by SCHIBLI, Roger
European journal of nuclear medicine and molecular imaging, 2002, Vol.29 (11), p.1529-1542
10.
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
by Cavo, Michele
The lancet oncology, 2017-04, Vol.18 (4), p.e206-e217
11.
Radiopharmaceutical development of radiolabelled peptides
by Fani, Melpomeni
European journal of nuclear medicine and molecular imaging, 2012-03-03, Vol.39 (Suppl 1), p.11-30
12.
Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [Ga-68]SB3 and PET/CT
by Maina, T
European journal of nuclear medicine and molecular imaging, 2016, Vol.43 (5), p.964-973
13.
Repeated injections of 131I-rituximab show patient-specific stable biodistribution and tissue kinetics
by Antonescu, Cristian
European journal of nuclear medicine and molecular imaging, 2005-08, Vol.32 (8), p.943-951
14.
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
by Zaknun, JJ
European journal of nuclear medicine and molecular imaging, 2013, Vol.40 (5), p.800-816
15.
Radiotheranostics: a roadmap for future development
by Herrmann, Ken
The lancet oncology, 2020-03, Vol.21 (3), p.e146-e156
16.
The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy
by Chiesa, C
European journal of nuclear medicine and molecular imaging, 2017, Vol.44 (11), p.1783-1786
17.
The EANM practice guidelines for bone scintigraphy
by Van den Wyngaert, T
European journal of nuclear medicine and molecular imaging, 2016-08, Vol.43 (9), p.1723-1738
18.
Renal function affects absorbed dose to the kidneys and haematological toxicity during 177Lu-DOTATATE treatment
by Svensson, Johanna
European journal of nuclear medicine and molecular imaging, 2015-02-06, Vol.42 (6), p.947-955
19.
Excretion of radionuclides in human breast milk after nuclear medicine examinations. Biokinetic and dosimetric data and recommendations on breastfeeding interruption
by Leide-Svegborn, Sigrid
European journal of nuclear medicine and molecular imaging, 2016-01-06, Vol.43 (5), p.808-821
20.
(177)Lu-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: a phase II study
by Agarwal, Krishan Kant
European journal of nuclear medicine and molecular imaging, 2015-01, Vol.42 (1), p.79
